Epigenomics

杂志介绍

Epigenomics杂志介绍

《Epigenomics》是一本以English为主的未开放获取国际优秀期刊，中文名称表观基因组学，本刊主要出版、报道医学-GENETICS & HEREDITY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为3，最新CiteScore 指数为5.8。

本刊近期中国学者发表的论文主要有：

• Combining EZH2 inhibitors with other therapies for solid tumors: more choices for better effects

  Author: Huang, Rong; Wu, Yirong; Zou, Zhengyun

• miR-4732-3p prevents lung cancer progression via inhibition of the TBX15/TNFSF11 axis

  Author: Li, Pengfei; Li, Ying; Bai, Shuping; Zhang, Yu; Zhao, Ling

• Analysis on methylation and expression of PSMB8 and its correlation with immunity and immunotherapy in lung adenocarcinoma

  Author: Xie, Tongji; Fan, Guangyu; Huang, Liling; Lou, Ning; Han, Xiaohong; Xing, Puyuan; Shi, Yuankai

• Low-dose 5-aza-2' -deoxycytidine protects against early renal injury by increasing klotho expression

  Author: Zhao, Yanlong; Zeng, Xiaorong; Xu, Xinli; Wang, Wenjing; Xu, Lei; Wu, Yiying; Li, Hang

英文介绍

Epigenomics杂志英文介绍

Epigenomics provides the forum to address the rapidly progressing research developments in this ever-expanding field; to report on the major challenges ahead and critical advances that are propelling the science forward. The journal delivers this information in concise, at-a-glance article formats – invaluable to a time constrained community.

Substantial developments in our current knowledge and understanding of genomics and epigenetics are constantly being made, yet this field is still in its infancy. Epigenomics provides a critical overview of the latest and most significant advances as they unfold and explores their potential application in the clinical setting.